Nuvation Bio, Inc. (NUVB)
4.75
+0.07
(+1.50%)
USD |
NYSE |
Oct 15, 16:00
4.85
+0.10
(+2.11%)
Pre-Market: 04:38
Nuvation Bio Cash from Operations (TTM) : -120.52M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -120.52M |
| March 31, 2026 | -125.73M |
| December 31, 2025 | -173.43M |
| September 30, 2025 | -190.00M |
| June 30, 2025 | -168.19M |
| March 31, 2025 | -157.34M |
| December 31, 2024 | -130.41M |
| September 30, 2024 | -99.14M |
| June 30, 2024 | -84.21M |
| March 31, 2024 | -64.37M |
| December 31, 2023 | -68.00M |
| September 30, 2023 | -69.14M |
| Date | Value |
|---|---|
| June 30, 2023 | -81.08M |
| March 31, 2023 | -90.51M |
| December 31, 2022 | -96.11M |
| September 30, 2022 | -103.42M |
| June 30, 2022 | -88.48M |
| March 31, 2022 | -78.39M |
| December 31, 2021 | -68.19M |
| September 30, 2021 | -57.64M |
| June 30, 2021 | -52.54M |
| March 31, 2021 | -42.54M |
| December 31, 2020 | -36.53M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Bristol Myers Squibb Co. | 12.78B |
| Johnson & Johnson | -- |
| Pfizer Inc. | 13.40B |
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |